Browse comprehensive guides on diseases — evidence-based content reviewed by MyMedicPlus Medical Review Board.
206 entries
206 results
Comprehensive guide to hair thinning and diffuse hair loss — covering androgenetic alopecia, telogen effluvium, thyroid disease, iron deficiency, and treatments including minoxidil, finasteride, PRP, and low-level laser therapy.
Comprehensive guide to hairy cell leukemia (HCL). Covers BRAF V600E mutation, cladribine (2-CdA) treatment achieving 80-90% complete remission, pentostatin, rituximab combination, vemurafenib for relapsed disease, and moxetumomab pasudotox.
Clinical guide to head and neck cancers — including oral cavity, oropharynx, larynx, hypopharynx, and nasopharynx. Covers HPV-related cancers, TNM staging, surgery, chemoradiation, and immunotherapy per NCCN guidelines.
Comprehensive guide to head and neck cancers including oral cavity, pharynx, larynx, and salivary gland tumors. Learn about HPV role, cisplatin-based chemoradiation, and targeted therapies at MyMedicPlus.
Learn about primary cardiac tumors including myxoma and angiosarcoma, and cardiac metastases. Explore symptoms, diagnosis with echocardiography and cardiac MRI, and surgical treatment options.
Clinical guide to hemangiomas — the most common benign vascular tumors of infancy and childhood. Covers infantile vs congenital types, propranolol therapy, indications for intervention, and hepatic hemangioma management.
Clinical guide to hemorrhoids (piles) — the most common anorectal condition. Covers internal vs external classification, Goligher grading, rubber band ligation, sclerotherapy, hemorrhoidectomy, and dietary prevention.
Comprehensive guide to hepatocellular carcinoma (HCC). Explore BCLC staging system, atezolizumab plus bevacizumab first-line therapy, sorafenib, TACE, surgical resection, and liver transplantation for HCC.
Clinical guide to hepatocellular carcinoma (HCC) — the most common primary liver malignancy. Covers cirrhosis and hepatitis B/C risk factors, BCLC staging, liver transplantation, TACE, sorafenib, and atezolizumab-bevacizumab.
Comprehensive guide to Hodgkin lymphoma. Covers Reed-Sternberg cells, Ann Arbor staging, ABVD and BV-AVD chemotherapy, PET-adapted therapy, brentuximab vedotin, nivolumab/pembrolizumab for relapsed disease, and long-term survivor surveillance.
Comprehensive guide to hypopharyngeal cancer. Covers piriform sinus SCC, larynx-preservation chemoradiation (EORTC 24891), total laryngopharyngectomy, pembrolizumab (KEYNOTE-048) for recurrent/metastatic disease, and tobacco/alcohol prevention.
Comprehensive guide to intraocular (uveal) melanoma. Covers GEP class 1A/1B/2 prognostic testing, BAP1 mutations, I-125 plaque brachytherapy, proton beam therapy, enucleation, and tebentafusp (IMCgp100) for HLA-A*02:01-positive metastatic disease.
Our patient support team can guide you to the best hospitals, doctors, and treatments based on your specific needs.
Medical Disclaimer: The information on MyMedicPlus is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site.